Prashant Mujumdar

522 total citations
18 papers, 385 citations indexed

About

Prashant Mujumdar is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Prashant Mujumdar has authored 18 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 13 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Prashant Mujumdar's work include Synthesis and Catalytic Reactions (7 papers), Enzyme function and inhibition (6 papers) and Chemical Synthesis and Analysis (4 papers). Prashant Mujumdar is often cited by papers focused on Synthesis and Catalytic Reactions (7 papers), Enzyme function and inhibition (6 papers) and Chemical Synthesis and Analysis (4 papers). Prashant Mujumdar collaborates with scholars based in Australia, Russia and Italy. Prashant Mujumdar's co-authors include Sally‐Ann Poulsen, Claudiu T. Supuran, Mikhail Krasavin, Thomas S. Peat, M. Sasikumar, Chiara Riganti, Joanna Kopecka, Silvia Bua, Daniela Vullo and M. Muthukrishnan and has published in prestigious journals such as Journal of Medicinal Chemistry, Biotechnology Advances and Tetrahedron Letters.

In The Last Decade

Prashant Mujumdar

18 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prashant Mujumdar Australia 12 278 205 79 19 18 18 385
B. Masjost Switzerland 7 178 0.6× 224 1.1× 38 0.5× 17 0.9× 21 1.2× 7 383
Kelvin Cooper United States 15 449 1.6× 331 1.6× 111 1.4× 10 0.5× 8 0.4× 30 714
Maria Fridén‐Saxin Sweden 10 343 1.2× 127 0.6× 142 1.8× 14 0.7× 11 0.6× 12 495
Motomichi Kono Japan 11 311 1.1× 227 1.1× 58 0.7× 10 0.5× 32 1.8× 33 504
Mark S. Tichenor United States 11 281 1.0× 215 1.0× 122 1.5× 4 0.2× 12 0.7× 14 455
Balu Balasubramanian United States 13 261 0.9× 155 0.8× 51 0.6× 8 0.4× 10 0.6× 33 439
John W. Butcher United States 11 199 0.7× 180 0.9× 48 0.6× 7 0.4× 15 0.8× 14 407
Jun Niijima Japan 11 359 1.3× 259 1.3× 55 0.7× 11 0.6× 29 1.6× 12 544
Thomas Brumby Germany 11 430 1.5× 136 0.7× 78 1.0× 14 0.7× 23 1.3× 18 511
Gaetano Correale Italy 9 323 1.2× 118 0.6× 45 0.6× 13 0.7× 9 0.5× 11 421

Countries citing papers authored by Prashant Mujumdar

Since Specialization
Citations

This map shows the geographic impact of Prashant Mujumdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Mujumdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Mujumdar more than expected).

Fields of papers citing papers by Prashant Mujumdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashant Mujumdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Mujumdar. The network helps show where Prashant Mujumdar may publish in the future.

Co-authorship network of co-authors of Prashant Mujumdar

This figure shows the co-authorship network connecting the top 25 collaborators of Prashant Mujumdar. A scholar is included among the top collaborators of Prashant Mujumdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashant Mujumdar. Prashant Mujumdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mujumdar, Prashant, Joanna Kopecka, Silvia Bua, et al.. (2019). Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma. Journal of Medicinal Chemistry. 62(8). 4174–4192. 30 indexed citations
2.
Salaroglio, Iris C., Prashant Mujumdar, Laura Annovazzi, et al.. (2018). Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein–Mediated Resistance to Temozolomide in Glioblastoma. Molecular Cancer Therapeutics. 17(12). 2598–2609. 36 indexed citations
3.
Mujumdar, Prashant, Silvia Bua, Claudiu T. Supuran, Thomas S. Peat, & Sally‐Ann Poulsen. (2018). Synthesis, structure and bioactivity of primary sulfamate-containing natural products. Bioorganic & Medicinal Chemistry Letters. 28(17). 3009–3013. 16 indexed citations
4.
Chrysanthopoulos, Panagiotis K., Prashant Mujumdar, Lucy A. Woods, et al.. (2017). Identification of a New Zinc Binding Chemotype by Fragment Screening. Journal of Medicinal Chemistry. 60(17). 7333–7349. 24 indexed citations
5.
Mujahid, Mohammad, et al.. (2017). An efficient synthesis of the opioid analgesic (R)-phenampromide via an aziridinium ion. Tetrahedron Asymmetry. 28(7). 983–986. 4 indexed citations
6.
Mujumdar, Prashant, Kathryn F. Tonissen, Daniela Vullo, et al.. (2016). An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C. Journal of Medicinal Chemistry. 59(11). 5462–5470. 49 indexed citations
7.
Supuran, Claudiu T., Stanislav Kalinin, Muhammet Tanç, et al.. (2016). Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(sup1). 197–202. 23 indexed citations
8.
Mujumdar, Prashant, et al.. (2016). An alternate synthesis of appetite suppressant ( R )-2-benzylmorpholine employing Sharpless asymmetric epoxidation strategy. Tetrahedron Letters. 57(8). 861–863. 13 indexed citations
9.
Mujumdar, Prashant, Paul Taylor, Mark J. Coster, et al.. (2015). Panel docking of small-molecule libraries — Prospects to improve efficiency of lead compound discovery. Biotechnology Advances. 33(6). 941–947. 21 indexed citations
10.
Krasavin, Mikhail, et al.. (2015). Library of diversely substituted 2-(quinolin-4-yl)imidazolines delivers novel non-cytotoxic antitubercular leads. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(6). 1146–1155. 11 indexed citations
11.
Mujumdar, Prashant & Sally‐Ann Poulsen. (2015). Natural Product Primary Sulfonamides and Primary Sulfamates. Journal of Natural Products. 78(6). 1470–1477. 68 indexed citations
12.
Mujumdar, Prashant, et al.. (2015). Facile Pd-catalyzed amination of imidazolin-1-yl chloroazines under microwave irradiation: toward a new kinase-inhibitory chemotype. Tetrahedron Letters. 56(21). 2827–2831. 6 indexed citations
13.
Mujumdar, Prashant, Christophe Morisseau, Sung Hee Hwang, et al.. (2014). Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core. European Journal of Medicinal Chemistry. 84. 160–172. 31 indexed citations
14.
Mujumdar, Prashant, et al.. (2014). An expeditious and atom-economic synthesis of lead-like, medicinally important 4,5-dihydropyrazolo[1,5-a]pyrazin-6-ones. Tetrahedron Letters. 55(42). 5732–5735. 2 indexed citations
15.
Krasavin, Mikhail, et al.. (2014). Atom-Economical Construction of a Rare 6,7-Dihydropyrido[3′,2′:4,5]imidazo[1,2-d][1,4]benzodiazepine Scaffold. Synlett. 25(16). 2323–2326. 2 indexed citations
16.
Mujumdar, Prashant, Tanja Grkovic, & Mikhail Krasavin. (2013). A simple two-step access to diversely substituted imidazo[4,5-b]pyridines and benzimidazoles from readily available 2-imidazolines. Tetrahedron Letters. 54(26). 3336–3340. 9 indexed citations
17.
Mujumdar, Prashant, et al.. (2012). An alternate synthesis of enantiomerically pure levetiracetam (Keppra®). Tetrahedron Asymmetry. 23(20-21). 1512–1515. 16 indexed citations
18.
Muthukrishnan, M., et al.. (2011). First asymmetric synthesis of the antiepileptic drug Lacosamide (Vimpat®) based on a hydrolytic kinetic resolution strategy. Tetrahedron Asymmetry. 22(12). 1353–1357. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Masjost Breakdown of academic impact, for papers by Kelvin Cooper Breakdown of academic impact, for papers by Maria Fridén‐Saxin Breakdown of academic impact, for papers by Motomichi Kono Breakdown of academic impact, for papers by Mark S. Tichenor Breakdown of academic impact, for papers by Balu Balasubramanian Breakdown of academic impact, for papers by John W. Butcher Breakdown of academic impact, for papers by Jun Niijima Breakdown of academic impact, for papers by Thomas Brumby Breakdown of academic impact, for papers by Gaetano Correale
Rankless by CCL
2026